Oruka TherapeuticsORKA 13F holders, Q3 2024 (September 30) 42 holders
1 famous investor
$24.60 avg. 13F price*
At the end of Q3 2024 , 42 institutions reported holding Oruka Therapeutics Inc. (ORKA) in their 13F filings. The largest holders were FMR LLC ($114.8M), Fairmount Funds Management LLC ($78.7M) and Venrock Adviser, LLC ($75.6M). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).
Company Oruka Therapeutics Inc.
CUSIP 687604108
Latest filing quarter Q2 2026 History Number of 13F holders
Total Exit/New Position Q3 2024 Institutions Total Value New Positions 42 $603.6M Exits 0 $0
Ownership 42 holders Portfolio Manager % of Holder's Portfolio Change Shares Value ▼ FMR LLC 0.01% New 4,682,300 $114.8M Fairmount Funds Management LLC 6.38% New 3,211,922 $78.7M Venrock Adviser, LLC 3.96% New 3,085,620 $75.6M RTW Investments, LP 0.66% New 1,850,648 $45.4M Commodore Capital LP 2.10% New 1,369,714 $33.6M Deep Track Capital, LP 0.97% New 1,235,187 $30.3M Perceptive Advisors LLC 0.65% New 1,235,187 $30.3M Franklin Resources Inc. 0.01% New 720,547 $20.0M Avidity Partners Management LP 0.99% New 790,926 $19.4M Paradigm Biocapital Advisors LP 0.62% New 719,660 $17.6M Braidwell LP 0.54% New 515,726 $12.6M Great Point Partners LLC 3.81% New 514,659 $12.6M Point72 Asset Management 0.04% New 482,330 $11.8M Frazier Life Sciences Management, L.P. 0.47% New 477,327 $11.7M Redmile Group, LLC 0.59% New 411,728 $10.1M Woodline Partners LP 0.08% New 390,795 $9.6M SR One Capital Management, LP 1.84% New 375,330 $9.2M Affinity Asset Advisors, LLC 1.43% New 349,836 $8.6M Cable Car Capital, LP 9.21% New 333,371 $8.2M Driehaus Capital Management LLC 0.07% New 308,795 $7.6M T. Rowe Price Associates Inc. 0.00% New 279,648 $6.9M Logos Global Management LP 0.71% New 257,330 $6.3M Janus Henderson Group PLC 0.00% New 236,116 $5.8M Adage Capital Partners Gp, L.L.C. 0.01% New 200,000 $4.9M TD Asset Management Inc 0.00% New 95,076 $2.2M Wellington Management Group LLP 0.00% New 82,137 $2.0M Morgan Stanley 0.00% New 68,133 $1.7M Cowen and Company, LLC 0.05% New 58,332 $1.4M Manufacturers Life Insurance Company, The 0.00% New 42,298 $1.0M Qube Research & Technologies Ltd 0.00% New 41,360 $1.0M Vanguard Group Inc. 0.00% New 37,798 $926K Citigroup Inc. 0.00% New 26,720 $655K Ensign Peak Advisors, Inc 0.00% New 25,000 $613K BlackRock, Inc. 0.00% — 21,567 $529K Geode Capital Management, LLC 0.00% New 13,984 $343K ADAR1 Capital Management, LLC 0.05% New 11,187 $274K Tower Research Capital LLC (TRC) 0.00% New 965 $24K Activest Wealth Management 0.00% New 166 $4K New England Capital Financial Advisors LLC 0.00% New 41 $1K Parallel Advisors, LLC 0.00% New 20 $490 Bank of America Corp. 0.00% New 15 $368 Danske Bank A/S 0.00% New 2 $49
"% of holder's portfolio" is ORKA's weight in each manager's 13F, not the share of Oruka Therapeutics Inc. the manager owns.